Morphine/dextromethorphan - Endo
Alternative Names: Dextromethorphan/morphine - Endo; EN 3231; MorphiDexLatest Information Update: 11 Jul 2006
At a glance
- Originator Endo Pharmaceuticals
- Class Morphinans; Opioid analgesics; Small molecules
- Mechanism of Action Glutamate receptor antagonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Cancer pain
Most Recent Events
- 11 Jul 2006 Discontinued - Phase-III for Cancer pain in USA (PO)
- 10 Jan 2003 Phase-III clinical trials in Cancer pain in USA (PO)
- 30 Oct 2002 MorphiDex did not meet primary and secondary endpoints in the two phase III studies